Epigenetic mechanism and target therapy of uhrf1 protein complex in malignancies

33Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

Abstract

Ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 (UHRF1) functions as an epigenetic regulator recruiting PCNA, DNMT1, histone deacetylase 1, G9a, SuV39H, herpes virus-associated ubiquitin-specific protease, and Tat-interactive protein by multiple corresponding domains of DNA and H3 to maintain DNA methylation and histone modifications. Overexpression of UHRF1 has been found as a potential biomarker in various cancers resulting in either DNA hypermethylation or global DNA hypomethylation, which participates in the occurrence, progression, and invasion of cancer. The role of UHRF1 in the reciprocal interaction between DNA methylation and histone modifications, the dynamic structural transformation of UHRF1 protein within epigenetic code replication machinery in epigenetic regulations, as well as modifications during cell cycle and chemotherapy targeting UHRF1 are evaluated in this study.

Cite

CITATION STYLE

APA

Xue, B., Zhao, J., Feng, P., Xing, J., Wu, H., & Li, Y. (2019). Epigenetic mechanism and target therapy of uhrf1 protein complex in malignancies. OncoTargets and Therapy. Dove Medical Press Ltd. https://doi.org/10.2147/OTT.S192234

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free